ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pertuzumab Biosimilars Market Research Report 2025
Published Date: 2025-06-03
|
Report Code: QYRE-Auto-15Z16458
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pertuzumab Biosimilars Market Research Report 2023
BUY CHAPTERS

Global Pertuzumab Biosimilars Market Research Report 2025

Code: QYRE-Auto-15Z16458
Report
2025-06-03
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Qilu Pharmaceutical
Shanghai Henlius Biotech
Cinnagen
NeuClone
Zhengda Tianqing Company
EDEN Biologics

Pertuzumab Biosimilars Market

The global market for Pertuzumab Biosimilars was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pertuzumab is a recombinant humanized monoclonal antibody targeting HER2
North American market for Pertuzumab Biosimilars is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pertuzumab Biosimilars is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Pertuzumab Biosimilars include Qilu Pharmaceutical, Zhengda Tianqing Company, Shanghai Henlius Biotech, CinnaGen, EDEN Biologics, NeuClone, Serum Institute of India, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pertuzumab Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertuzumab Biosimilars.
The Pertuzumab Biosimilars market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pertuzumab Biosimilars market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pertuzumab Biosimilars manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pertuzumab Biosimilars Market Report

Report Metric Details
Report Name Pertuzumab Biosimilars Market
Segment by Type
  • Human Pertuzumab
  • Animal Source Pertuzumab
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Qilu Pharmaceutical, Zhengda Tianqing Company, Shanghai Henlius Biotech, CinnaGen, EDEN Biologics, NeuClone, Serum Institute of India
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pertuzumab Biosimilars manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pertuzumab Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Pertuzumab Biosimilars Market report?

Ans: The main players in the Pertuzumab Biosimilars Market are Qilu Pharmaceutical, Zhengda Tianqing Company, Shanghai Henlius Biotech, CinnaGen, EDEN Biologics, NeuClone, Serum Institute of India

What are the Application segmentation covered in the Pertuzumab Biosimilars Market report?

Ans: The Applications covered in the Pertuzumab Biosimilars Market report are Hospital, Clinic

What are the Type segmentation covered in the Pertuzumab Biosimilars Market report?

Ans: The Types covered in the Pertuzumab Biosimilars Market report are Human Pertuzumab, Animal Source Pertuzumab

1 Pertuzumab Biosimilars Market Overview
1.1 Product Definition
1.2 Pertuzumab Biosimilars by Type
1.2.1 Global Pertuzumab Biosimilars Market Value Comparison by Type (2024 VS 2031)
1.2.2 Human Pertuzumab
1.2.3 Animal Source Pertuzumab
1.3 Pertuzumab Biosimilars by Application
1.3.1 Global Pertuzumab Biosimilars Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Pertuzumab Biosimilars Market Size Estimates and Forecasts
1.4.1 Global Pertuzumab Biosimilars Revenue 2020-2031
1.4.2 Global Pertuzumab Biosimilars Sales 2020-2031
1.4.3 Global Pertuzumab Biosimilars Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pertuzumab Biosimilars Market Competition by Manufacturers
2.1 Global Pertuzumab Biosimilars Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pertuzumab Biosimilars Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pertuzumab Biosimilars Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pertuzumab Biosimilars, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pertuzumab Biosimilars, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pertuzumab Biosimilars, Product Type & Application
2.7 Global Key Manufacturers of Pertuzumab Biosimilars, Date of Enter into This Industry
2.8 Global Pertuzumab Biosimilars Market Competitive Situation and Trends
2.8.1 Global Pertuzumab Biosimilars Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pertuzumab Biosimilars Players Market Share by Revenue
2.8.3 Global Pertuzumab Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pertuzumab Biosimilars Market Scenario by Region
3.1 Global Pertuzumab Biosimilars Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pertuzumab Biosimilars Sales by Region: 2020-2031
3.2.1 Global Pertuzumab Biosimilars Sales by Region: 2020-2025
3.2.2 Global Pertuzumab Biosimilars Sales by Region: 2026-2031
3.3 Global Pertuzumab Biosimilars Revenue by Region: 2020-2031
3.3.1 Global Pertuzumab Biosimilars Revenue by Region: 2020-2025
3.3.2 Global Pertuzumab Biosimilars Revenue by Region: 2026-2031
3.4 North America Pertuzumab Biosimilars Market Facts & Figures by Country
3.4.1 North America Pertuzumab Biosimilars Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pertuzumab Biosimilars Sales by Country (2020-2031)
3.4.3 North America Pertuzumab Biosimilars Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pertuzumab Biosimilars Market Facts & Figures by Country
3.5.1 Europe Pertuzumab Biosimilars Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pertuzumab Biosimilars Sales by Country (2020-2031)
3.5.3 Europe Pertuzumab Biosimilars Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pertuzumab Biosimilars Market Facts & Figures by Region
3.6.1 Asia Pacific Pertuzumab Biosimilars Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pertuzumab Biosimilars Sales by Region (2020-2031)
3.6.3 Asia Pacific Pertuzumab Biosimilars Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pertuzumab Biosimilars Market Facts & Figures by Country
3.7.1 Latin America Pertuzumab Biosimilars Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pertuzumab Biosimilars Sales by Country (2020-2031)
3.7.3 Latin America Pertuzumab Biosimilars Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pertuzumab Biosimilars Market Facts & Figures by Country
3.8.1 Middle East and Africa Pertuzumab Biosimilars Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pertuzumab Biosimilars Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pertuzumab Biosimilars Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pertuzumab Biosimilars Sales by Type (2020-2031)
4.1.1 Global Pertuzumab Biosimilars Sales by Type (2020-2025)
4.1.2 Global Pertuzumab Biosimilars Sales by Type (2026-2031)
4.1.3 Global Pertuzumab Biosimilars Sales Market Share by Type (2020-2031)
4.2 Global Pertuzumab Biosimilars Revenue by Type (2020-2031)
4.2.1 Global Pertuzumab Biosimilars Revenue by Type (2020-2025)
4.2.2 Global Pertuzumab Biosimilars Revenue by Type (2026-2031)
4.2.3 Global Pertuzumab Biosimilars Revenue Market Share by Type (2020-2031)
4.3 Global Pertuzumab Biosimilars Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pertuzumab Biosimilars Sales by Application (2020-2031)
5.1.1 Global Pertuzumab Biosimilars Sales by Application (2020-2025)
5.1.2 Global Pertuzumab Biosimilars Sales by Application (2026-2031)
5.1.3 Global Pertuzumab Biosimilars Sales Market Share by Application (2020-2031)
5.2 Global Pertuzumab Biosimilars Revenue by Application (2020-2031)
5.2.1 Global Pertuzumab Biosimilars Revenue by Application (2020-2025)
5.2.2 Global Pertuzumab Biosimilars Revenue by Application (2026-2031)
5.2.3 Global Pertuzumab Biosimilars Revenue Market Share by Application (2020-2031)
5.3 Global Pertuzumab Biosimilars Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Qilu Pharmaceutical
6.1.1 Qilu Pharmaceutical Company Information
6.1.2 Qilu Pharmaceutical Description and Business Overview
6.1.3 Qilu Pharmaceutical Pertuzumab Biosimilars Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Qilu Pharmaceutical Pertuzumab Biosimilars Product Portfolio
6.1.5 Qilu Pharmaceutical Recent Developments/Updates
6.2 Zhengda Tianqing Company
6.2.1 Zhengda Tianqing Company Company Information
6.2.2 Zhengda Tianqing Company Description and Business Overview
6.2.3 Zhengda Tianqing Company Pertuzumab Biosimilars Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Zhengda Tianqing Company Pertuzumab Biosimilars Product Portfolio
6.2.5 Zhengda Tianqing Company Recent Developments/Updates
6.3 Shanghai Henlius Biotech
6.3.1 Shanghai Henlius Biotech Company Information
6.3.2 Shanghai Henlius Biotech Description and Business Overview
6.3.3 Shanghai Henlius Biotech Pertuzumab Biosimilars Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shanghai Henlius Biotech Pertuzumab Biosimilars Product Portfolio
6.3.5 Shanghai Henlius Biotech Recent Developments/Updates
6.4 CinnaGen
6.4.1 CinnaGen Company Information
6.4.2 CinnaGen Description and Business Overview
6.4.3 CinnaGen Pertuzumab Biosimilars Sales, Revenue and Gross Margin (2020-2025)
6.4.4 CinnaGen Pertuzumab Biosimilars Product Portfolio
6.4.5 CinnaGen Recent Developments/Updates
6.5 EDEN Biologics
6.5.1 EDEN Biologics Company Information
6.5.2 EDEN Biologics Description and Business Overview
6.5.3 EDEN Biologics Pertuzumab Biosimilars Sales, Revenue and Gross Margin (2020-2025)
6.5.4 EDEN Biologics Pertuzumab Biosimilars Product Portfolio
6.5.5 EDEN Biologics Recent Developments/Updates
6.6 NeuClone
6.6.1 NeuClone Company Information
6.6.2 NeuClone Description and Business Overview
6.6.3 NeuClone Pertuzumab Biosimilars Sales, Revenue and Gross Margin (2020-2025)
6.6.4 NeuClone Pertuzumab Biosimilars Product Portfolio
6.6.5 NeuClone Recent Developments/Updates
6.7 Serum Institute of India
6.7.1 Serum Institute of India Company Information
6.7.2 Serum Institute of India Description and Business Overview
6.7.3 Serum Institute of India Pertuzumab Biosimilars Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Serum Institute of India Pertuzumab Biosimilars Product Portfolio
6.7.5 Serum Institute of India Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pertuzumab Biosimilars Industry Chain Analysis
7.2 Pertuzumab Biosimilars Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pertuzumab Biosimilars Production Mode & Process Analysis
7.4 Pertuzumab Biosimilars Sales and Marketing
7.4.1 Pertuzumab Biosimilars Sales Channels
7.4.2 Pertuzumab Biosimilars Distributors
7.5 Pertuzumab Biosimilars Customer Analysis
8 Pertuzumab Biosimilars Market Dynamics
8.1 Pertuzumab Biosimilars Industry Trends
8.2 Pertuzumab Biosimilars Market Drivers
8.3 Pertuzumab Biosimilars Market Challenges
8.4 Pertuzumab Biosimilars Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Qilu Pharmaceutical
Shanghai Henlius Biotech
Cinnagen
NeuClone
Zhengda Tianqing Company
EDEN Biologics
List of Tables
 Table 1. Global Pertuzumab Biosimilars Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pertuzumab Biosimilars Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pertuzumab Biosimilars Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pertuzumab Biosimilars Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pertuzumab Biosimilars Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pertuzumab Biosimilars Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pertuzumab Biosimilars Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pertuzumab Biosimilars Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pertuzumab Biosimilars, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pertuzumab Biosimilars, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pertuzumab Biosimilars, Product Type & Application
 Table 12. Global Key Manufacturers of Pertuzumab Biosimilars, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pertuzumab Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pertuzumab Biosimilars as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pertuzumab Biosimilars Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pertuzumab Biosimilars Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pertuzumab Biosimilars Sales Market Share by Region (2020-2025)
 Table 19. Global Pertuzumab Biosimilars Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pertuzumab Biosimilars Sales Market Share by Region (2026-2031)
 Table 21. Global Pertuzumab Biosimilars Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pertuzumab Biosimilars Revenue Market Share by Region (2020-2025)
 Table 23. Global Pertuzumab Biosimilars Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pertuzumab Biosimilars Revenue Market Share by Region (2026-2031)
 Table 25. North America Pertuzumab Biosimilars Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pertuzumab Biosimilars Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pertuzumab Biosimilars Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pertuzumab Biosimilars Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pertuzumab Biosimilars Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pertuzumab Biosimilars Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pertuzumab Biosimilars Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pertuzumab Biosimilars Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pertuzumab Biosimilars Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pertuzumab Biosimilars Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pertuzumab Biosimilars Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pertuzumab Biosimilars Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pertuzumab Biosimilars Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pertuzumab Biosimilars Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pertuzumab Biosimilars Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pertuzumab Biosimilars Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pertuzumab Biosimilars Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pertuzumab Biosimilars Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pertuzumab Biosimilars Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pertuzumab Biosimilars Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pertuzumab Biosimilars Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pertuzumab Biosimilars Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pertuzumab Biosimilars Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pertuzumab Biosimilars Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pertuzumab Biosimilars Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pertuzumab Biosimilars Sales (K Units) by Type (2020-2025)
 Table 51. Global Pertuzumab Biosimilars Sales (K Units) by Type (2026-2031)
 Table 52. Global Pertuzumab Biosimilars Sales Market Share by Type (2020-2025)
 Table 53. Global Pertuzumab Biosimilars Sales Market Share by Type (2026-2031)
 Table 54. Global Pertuzumab Biosimilars Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pertuzumab Biosimilars Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pertuzumab Biosimilars Revenue Market Share by Type (2020-2025)
 Table 57. Global Pertuzumab Biosimilars Revenue Market Share by Type (2026-2031)
 Table 58. Global Pertuzumab Biosimilars Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Pertuzumab Biosimilars Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Pertuzumab Biosimilars Sales (K Units) by Application (2020-2025)
 Table 61. Global Pertuzumab Biosimilars Sales (K Units) by Application (2026-2031)
 Table 62. Global Pertuzumab Biosimilars Sales Market Share by Application (2020-2025)
 Table 63. Global Pertuzumab Biosimilars Sales Market Share by Application (2026-2031)
 Table 64. Global Pertuzumab Biosimilars Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pertuzumab Biosimilars Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pertuzumab Biosimilars Revenue Market Share by Application (2020-2025)
 Table 67. Global Pertuzumab Biosimilars Revenue Market Share by Application (2026-2031)
 Table 68. Global Pertuzumab Biosimilars Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Pertuzumab Biosimilars Price (US$/Unit) by Application (2026-2031)
 Table 70. Qilu Pharmaceutical Company Information
 Table 71. Qilu Pharmaceutical Description and Business Overview
 Table 72. Qilu Pharmaceutical Pertuzumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Qilu Pharmaceutical Pertuzumab Biosimilars Product
 Table 74. Qilu Pharmaceutical Recent Developments/Updates
 Table 75. Zhengda Tianqing Company Company Information
 Table 76. Zhengda Tianqing Company Description and Business Overview
 Table 77. Zhengda Tianqing Company Pertuzumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Zhengda Tianqing Company Pertuzumab Biosimilars Product
 Table 79. Zhengda Tianqing Company Recent Developments/Updates
 Table 80. Shanghai Henlius Biotech Company Information
 Table 81. Shanghai Henlius Biotech Description and Business Overview
 Table 82. Shanghai Henlius Biotech Pertuzumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Shanghai Henlius Biotech Pertuzumab Biosimilars Product
 Table 84. Shanghai Henlius Biotech Recent Developments/Updates
 Table 85. CinnaGen Company Information
 Table 86. CinnaGen Description and Business Overview
 Table 87. CinnaGen Pertuzumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. CinnaGen Pertuzumab Biosimilars Product
 Table 89. CinnaGen Recent Developments/Updates
 Table 90. EDEN Biologics Company Information
 Table 91. EDEN Biologics Description and Business Overview
 Table 92. EDEN Biologics Pertuzumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. EDEN Biologics Pertuzumab Biosimilars Product
 Table 94. EDEN Biologics Recent Developments/Updates
 Table 95. NeuClone Company Information
 Table 96. NeuClone Description and Business Overview
 Table 97. NeuClone Pertuzumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. NeuClone Pertuzumab Biosimilars Product
 Table 99. NeuClone Recent Developments/Updates
 Table 100. Serum Institute of India Company Information
 Table 101. Serum Institute of India Description and Business Overview
 Table 102. Serum Institute of India Pertuzumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Serum Institute of India Pertuzumab Biosimilars Product
 Table 104. Serum Institute of India Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Pertuzumab Biosimilars Distributors List
 Table 108. Pertuzumab Biosimilars Customers List
 Table 109. Pertuzumab Biosimilars Market Trends
 Table 110. Pertuzumab Biosimilars Market Drivers
 Table 111. Pertuzumab Biosimilars Market Challenges
 Table 112. Pertuzumab Biosimilars Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pertuzumab Biosimilars
 Figure 2. Global Pertuzumab Biosimilars Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pertuzumab Biosimilars Market Share by Type: 2024 & 2031
 Figure 4. Human Pertuzumab Product Picture
 Figure 5. Animal Source Pertuzumab Product Picture
 Figure 6. Global Pertuzumab Biosimilars Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pertuzumab Biosimilars Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Global Pertuzumab Biosimilars Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Pertuzumab Biosimilars Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Pertuzumab Biosimilars Sales (2020-2031) & (K Units)
 Figure 13. Global Pertuzumab Biosimilars Average Price (US$/Unit) & (2020-2031)
 Figure 14. Pertuzumab Biosimilars Report Years Considered
 Figure 15. Pertuzumab Biosimilars Sales Share by Manufacturers in 2024
 Figure 16. Global Pertuzumab Biosimilars Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Pertuzumab Biosimilars Players: Market Share by Revenue in Pertuzumab Biosimilars in 2024
 Figure 18. Pertuzumab Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Pertuzumab Biosimilars Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Pertuzumab Biosimilars Sales Market Share by Country (2020-2031)
 Figure 21. North America Pertuzumab Biosimilars Revenue Market Share by Country (2020-2031)
 Figure 22. United States Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Pertuzumab Biosimilars Sales Market Share by Country (2020-2031)
 Figure 25. Europe Pertuzumab Biosimilars Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Pertuzumab Biosimilars Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Pertuzumab Biosimilars Revenue Market Share by Region (2020-2031)
 Figure 33. China Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Pertuzumab Biosimilars Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Pertuzumab Biosimilars Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Pertuzumab Biosimilars Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Pertuzumab Biosimilars Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Pertuzumab Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Pertuzumab Biosimilars by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Pertuzumab Biosimilars by Type (2020-2031)
 Figure 52. Global Pertuzumab Biosimilars Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Pertuzumab Biosimilars by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Pertuzumab Biosimilars by Application (2020-2031)
 Figure 55. Global Pertuzumab Biosimilars Price (US$/Unit) by Application (2020-2031)
 Figure 56. Pertuzumab Biosimilars Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions